Xiaomeng Feng

711 total citations · 1 hit paper
21 papers, 552 citations indexed

About

Xiaomeng Feng is a scholar working on Molecular Biology, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Xiaomeng Feng has authored 21 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Epidemiology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Xiaomeng Feng's work include Antibiotic Resistance in Bacteria (4 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). Xiaomeng Feng is often cited by papers focused on Antibiotic Resistance in Bacteria (4 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). Xiaomeng Feng collaborates with scholars based in China, United States and Canada. Xiaomeng Feng's co-authors include Xia Gao, Zhencheng Sun, Shuo Wang, Yuan Xu, Yumei Jia, Guang Wang, Mohammed Khadeer, Noriyuki Namba, Keith A. Hruska and Harriet S. Tenenhouse and has published in prestigious journals such as Blood, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Xiaomeng Feng

19 papers receiving 549 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ferroptosis Enhanced Diabetic Renal Tubular Injury via HIF-1α/HO-1 Pathway in db/db Mice

2021 243 citations Xiaomeng Feng, Shuo Wang et al. Frontiers in Endocrinology profile →

Peers

Xiaomeng Feng

PRM

NEPHR

EDM

Fengxun Liu China

De Xie China

Mohsen Honarpisheh Germany

Han Zhu China

Yingjin Qiao China

Muhammad Tarek Abdel Ghafar Egypt

Qi Bian China

Channa Zhang China

Jianan Zou China

Hermann Joseph Gröne Germany

Fengxun Liu China

Xiaomeng Feng

259 ×1.1

124 ×0.6

PRM

174 ×1.1

108 ×1.3

NEPHR

31 ×0.4

EDM

Citations per year, relative to Xiaomeng Feng Xiaomeng Feng (= 1×) peers Fengxun Liu

Countries citing papers authored by Xiaomeng Feng

Since Specialization

Citations

This map shows the geographic impact of Xiaomeng Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomeng Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomeng Feng more than expected).

Fields of papers citing papers by Xiaomeng Feng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaomeng Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomeng Feng. The network helps show where Xiaomeng Feng may publish in the future.

Co-authorship network of co-authors of Xiaomeng Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaomeng Feng. A scholar is included among the top collaborators of Xiaomeng Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaomeng Feng. Xiaomeng Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Hui, Xiaomeng Feng, Qingsong Lin, et al.. (2025). Clinical characteristics and efficacy of short-course antibiotic therapy for Staphylococcus aureus bacteremia in hematological patients. Microbiology Spectrum. 13(9). e0232524–e0232524.

Li, Jia, Wenjing Guo, Jieru Wang, et al.. (2024). Strong Homology Between Colonizing and Bloodstream Carbapenem-Resistant Acinetobacter Spp.: Implications for Empiric Antibiotic Therapy in Hematological Patients. Infection and Drug Resistance. Volume 17. 1827–1838. 2 indexed citations

Wang, Jieru, Li Liu, Xiaomeng Feng, et al.. (2024). Clinical Characteristics, Prognosis Factors and Metagenomic Next-Generation Sequencing Diagnosis of Mucormycosis in patients With Hematologic Diseases. Mycopathologia. 189(4). 71–71. 2 indexed citations

Guo, Wenjing, Qingsong Lin, Jia Li, et al.. (2024). Stenotrophomonas maltophilia bacteremia in adult patients with hematological diseases: clinical characteristics and risk factors for 28-day mortality. Microbiology Spectrum. 13(1). e0101124–e0101124. 7 indexed citations

Feng, Xiaomeng, Jia Li, Jieru Wang, et al.. (2023). Is Short-Course Antibiotic Therapy Suitable for Pseudomonas aeruginosa Bloodstream Infections in Onco-hematology Patients With Febrile Neutropenia? Results of a Multi-institutional Analysis. Clinical Infectious Diseases. 78(3). 518–525. 10 indexed citations

Li, Jia, Xiaomeng Feng, Jieru Wang, et al.. (2023). Acinetobacter spp. bloodstream infection in hematological patients: a 10-year single-center study. BMC Infectious Diseases. 23(1). 796–796. 7 indexed citations

Chang, Jing, et al.. (2022). TangShenWeiNing Formula Prevents Diabetic Nephropathy by Protecting Podocytes Through the SIRT1/HIF-1α Pathway. Frontiers in Endocrinology. 13. 888611–888611. 11 indexed citations

Feng, Xiaomeng, Jing Huang, Yan Peng, & Yuan Xu. (2021). Association between decreased thyroid stimulating hormone and hyperuricemia in type 2 diabetic patients with early-stage diabetic kidney disease. BMC Endocrine Disorders. 21(1). 1–1. 19 indexed citations

Feng, Xiaomeng, et al.. (2021). Ferroptosis Enhanced Diabetic Renal Tubular Injury via HIF-1α/HO-1 Pathway in db/db Mice. Frontiers in Endocrinology. 12. 626390–626390. 243 indexed citations breakdown →

10.

Feng, Xiaomeng, et al.. (2021). PPAR-α Agonist Fenofibrate Prevented Diabetic Nephropathy by Inhibiting M1 Macrophages via Improving Endothelial Cell Function in db/db Mice. Frontiers in Medicine. 8. 652558–652558. 31 indexed citations

11.

Feng, Xiaomeng, Han Su, Xiaochen He, Jian‐Xiong Chen, & Heng Zeng. (2020). SIRT3 Deficiency Sensitizes Angiotensin-II-Induced Renal Fibrosis. Cells. 9(11). 2510–2510. 32 indexed citations

12.

Gao, Xia, Min Liu, Ning Yang, et al.. (2018). Diffuse Myocardial Injuries are Present in Subclinical Hypothyroidism: A Clinical Study Using Myocardial T1-mapping Quantification. Scientific Reports. 8(1). 4999–4999. 16 indexed citations

13.

Feng, Xiaomeng, Xia Gao, Yumei Jia, & Yuan Xu. (2017). PPAR-α Agonist Fenofibrate Reduces Insulin Resistance in Impaired Glucose Tolerance Patients with Hypertriglyceridemia: A Cross-Sectional Study. Diabetes Therapy. 8(2). 433–444. 10 indexed citations

14.

Feng, Xiaomeng, et al.. (2017). Low apoA-I is associated with insulin resistance in patients with impaired glucose tolerance: a cross-sectional study. Lipids in Health and Disease. 16(1). 69–69. 25 indexed citations

15.

Feng, Xiaomeng, Xia Gao, Yumei Jia, Heng Zhang, & Yuan Xu. (2017). Atorvastatin Decreased Circulating RANTES Levels in Impaired Glucose Tolerance Patients with Hypercholesterolemia: An Interventional Study. Diabetes Therapy. 8(2). 309–319. 3 indexed citations

16.

Feng, Xiaomeng & Yuan Xu. (2017). Hyperhomocysteinemia as a Metabolic Risk Factor for Glucose Intolerance Among High-Risk Groups of Chinese Adults. Medical Science Monitor. 23. 2775–2781. 15 indexed citations

17.

Gao, Xia, Min Liu, Aijuan Qu, et al.. (2016). Native Magnetic Resonance T1-Mapping Identifies Diffuse Myocardial Injury in Hypothyroidism. PLoS ONE. 11(3). e0151266–e0151266. 22 indexed citations

18.

Feng, Xiaomeng, Xia Gao, Yumei Jia, et al.. (2016). PPAR-α Agonist Fenofibrate Decreased RANTES Levels in Type 2 Diabetes Patients with Hypertriglyceridemia. Medical Science Monitor. 22. 743–751. 20 indexed citations

19.

Feng, Xiaomeng, Xia Gao, Yumei Jia, et al.. (2015). PPAR-αAgonist Fenofibrate Decreased Serum Irisin Levels in Type 2 Diabetes Patients with Hypertriglyceridemia. PPAR Research. 2015. 1–8. 23 indexed citations

20.

Tenenhouse, Harriet S., et al.. (2001). Identification of the type II Na+-Pi cotransporter (Npt2) in the osteoclast and the skeletal phenotype of Npt2−/− mice. Bone. 29(5). 467–476. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact